Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-07

Clinical Trial Update: A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ORMD-0801 in patients with Type 2 diabetes mellitus has completed, and results were posted on May 7, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORMD-0801

Snippet

Sponsor: Oramed, Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2024-05-07